Home » Topics » Inflammatory, BioWorld Science

Inflammatory, BioWorld Science
RSS

Spingotec Therapeutics divulges DPP3 inhibitors

Nov. 22, 2017

First-in-human results provided for TR-Pharm's anti-interleukin-1 biologic RPH-104

Nov. 15, 2017

New yohimbine analogues synthesized at the University of Florida

Nov. 15, 2017

Novel NLRP3 inflammasome inhibitors presented by IFM Therapeutics

Nov. 3, 2017

Novel leukotriene A-4 hydrolase inhibitors identified at Novartis

Oct. 31, 2017

Allergan presents new fMet-Leu-Phe receptor modulators

Oct. 30, 2017

University of Texas, Immune Sensor divulge new cyclic GMP-AMP synthase inhibitors

Oct. 19, 2017

Blade Therapeutics patents novel calpain inhibitors

Oct. 4, 2017

Galapagos presents new sphingosine 1-phosphate receptor antagonists

Sep. 19, 2017

Novartis identifies potent, irreversible myeloperoxidase inhibitors for inflammation

Sep. 19, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...